BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 91 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2017. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,703,000 | +24.1% | 46,057 | +26.1% | 0.10% | +66.7% |
| Q3 2018 | $1,372,000 | -51.9% | 36,530 | -49.4% | 0.06% | -47.2% |
| Q2 2018 | $2,853,000 | +1.7% | 72,200 | -33.7% | 0.11% | +13.7% |
| Q1 2018 | $2,806,000 | +8.5% | 108,939 | +13.7% | 0.10% | +26.7% |
| Q4 2017 | $2,585,000 | – | 95,822 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |